SOX9 and obesity due to melanocortin 4 receptor deficiency: Moreover, we observed decreased AMPK activity and SOX9 levels in mouse chondrocytes upon FFA exposure (Fig. S7c) but increased levels after TMZ treatment (Fig. S7d), which was consistently observed in HFD mouse models and human OA samples from individuals with obesity (Fig. S7e, f).